Australia markets open in 40 minutes

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (300452.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
10.77-0.03 (-0.28%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 2.52B
Enterprise value 2.17B
Trailing P/E 16.07
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.14
Price/book (mrq)2.83
Enterprise value/revenue 2.62
Enterprise value/EBITDA 11.32

Trading information

Stock price history

Beta (5Y monthly) 0.24
52-week change 3-29.64%
S&P500 52-week change 324.13%
52-week high 315.68
52-week low 39.92
50-day moving average 312.24
200-day moving average 313.36

Share statistics

Avg vol (3-month) 33.71M
Avg vol (10-day) 31.73M
Shares outstanding 5234.45M
Implied shares outstanding 6237.27M
Float 8138.92M
% held by insiders 142.45%
% held by institutions 15.27%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.25
Forward annual dividend yield 42.32%
Trailing annual dividend rate 30.25
Trailing annual dividend yield 32.31%
5-year average dividend yield 41.53
Payout ratio 437.31%
Dividend date 3N/A
Ex-dividend date 429 May 2024
Last split factor 21.3:1
Last split date 326 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 19.53%
Operating margin (ttm)21.41%

Management effectiveness

Return on assets (ttm)7.29%
Return on equity (ttm)18.20%

Income statement

Revenue (ttm)829.23M
Revenue per share (ttm)3.53
Quarterly revenue growth (yoy)-4.00%
Gross profit (ttm)N/A
EBITDA 199.84M
Net income avi to common (ttm)161.96M
Diluted EPS (ttm)0.67
Quarterly earnings growth (yoy)0.90%

Balance sheet

Total cash (mrq)650.88M
Total cash per share (mrq)2.8
Total debt (mrq)299.93M
Total debt/equity (mrq)31.13%
Current ratio (mrq)3.90
Book value per share (mrq)3.84

Cash flow statement

Operating cash flow (ttm)123.33M
Levered free cash flow (ttm)43.74M